Reports- Allicin (CAS 539-86-6) Market | Page 2

Mexico, with sales, revenue and market share of Allicin (CAS 539-86-6), for each country, from 2012 to 2017; Chapter 5 and 6, to show the market by type and application, with sales, price, revenue, market share and growth rate by type, application, from 2012 to 2017; Chapter 7, 8 and 9, to analyze the segment market in United States, Canada and Mexico, by manufacturers, type and application, with sales, price, revenue and market share by manufacturers, types and applications; Chapter 10, Allicin (CAS 539-86-6) market forecast, by countries, type and application, with sales, price and revenue, from 2017 to 2022; Chapter 11, to analyze the manufacturing cost, key raw materials and manufacturing process etc. Chapter 12, to analyze the industrial chain, sourcing strategy and downstream end users (buyers); Chapter 13, to describe sales channel, distributors, traders, dealers etc. Chapter 14 and 15, to describe Allicin (CAS 539-86-6) Research Findings and Conclusion, Appendix, methodology and data source Ask for Discount at – http://www.360marketupdates.com/enquiry/request-discount/10596303 Table of Contents 1 Market Overview 1.1 Allicin (CAS 539-86-6) Introduction 1.2 Market Analysis by Type 1.2.1 Allicin Liquid 1.2.2 Allicin Powder 1.3 Market Analysis by Applications 1.3.1 Oral Dietary Supplement 1.3.2 External Application 1.4 Market Analysis by Countries 1.4.1 United States Status and Prospect (2012-2022) 1.4.2 Mexico Status and Prospect (2012-2022) 1.4.3 Canada Status and Prospect (2012-2022) 1.5 Market Dynamics 1.5.1 Market Opportunities 1.5.2 Market Risk 1.5.3 Market Driving Force 2 Manufacturers Profiles 2.1 Allicin International 2.1.1 Profile 2.1.2 Allicin (CAS 539-86-6) Type and Applications 2.1.2.1 Type 1 2.1.2.2 Type 2 2.1.3 Allicin International Allicin (CAS 539-86-6) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.1.4 Business Overview 2.1.5 Allicin International News 3 North America Allicin (CAS 539-86-6) Market Competition, by Manufacturer